“ACS showcased innovations and technological advancements in alcohol and drug testing,” says Felix J.E. Comeau, Chairman and CEO–ACS. “We have seen tremendous progress in addressing alcohol related risks and continue to see increased focus and research to improve countermeasures for new risks such as drug impaired driving and biometric identification”.

The Saf’IR™ Evolution is the industry’s first handheld infrared, evidential breath alcohol tester, ideal for law enforcement and able to withstand harsh conditions, making it a reliable tool for evidential testing.

The ALERT™ J5 is designed for law enforcement roadside breath screening and organizations focused on improving industrial safety. This handheld breath alcohol tester marries accuracy with sensible storage capabilities to combat alcohol impaired-driving and ensure road safety and the safety of your employees.

The RELIANT™ is a line of alcohol breath testing tools with biometric monitoring capabilities. Designed for the criminal justice industry, the RELIANT provides flexibility to those who require community supervision, home confinement or 24/7 remote monitoring while enabling monitoring personnel to remotely determine compliance.

“Biomed 2017 gave ACS a platform to demonstrate how our technology can aid the global healthcare systems and life sciences industries,” says Felix J.E. Comeau.